Setting Out to Conquer Germany's Cannabis Market
Cannabis flowers are part of the Cansativa medical product inventory. Hundreds of kilograms of cannabis products for the medical sector are stored here behind thick concrete walls., © dpa
Germany’s pledge to legalize cannabis is luring U.S. and Canadian companies to invest in Europe.
Since the legalization of cannabis in Canada in 2016, the establishment and expansion of plantations has led to large overcapacities that can only be cushioned with the help of export markets.
For Germany, Canada is already the most important country of origin for medicinal cannabis, which has been legalized in Germany in 2017. Germany, with its more than 83 million inhabitants, has become the largest market for medical cannabis in Europe and thus an interesting market for foreign investors.
To date, the import and export of recreational cannabis has been prohibited under the 1961 United Nations Convention on Narcotic Drugs. Canadian producers would therefore have to invest in new facilities in Germany, making it more likely that they will take over existing German companies.